Allison Steigler Selected Research

Allison Steigler Research Topics

31	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2005
7	Neoplasms (Cancer) 01/2022 - 11/2005
6	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2011
4	Disease Progression 12/2020 - 05/2011
2	Hemorrhage 12/2020 - 01/2020
2	Urinary Incontinence 12/2020 - 07/2017
2	Adenocarcinoma 09/2014 - 05/2007
1	Hematuria 12/2020
1	Dysuria 12/2020
1	Urethral Stricture 01/2020
1	Cancer Pain 01/2020
1	Osteonecrosis (Kienbock's Disease) 01/2019
1	Spinal Fractures 09/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Myocardial Infarction 06/2007
1	Lower Urinary Tract Symptoms 11/2005

26	AndrogensIBA 01/2022 - 11/2005
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 11/2008
4	Zoledronic Acid (Zometa)FDA Link 01/2020 - 09/2014
2	Pharmaceutical PreparationsIBA 01/2019 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 02/2012 - 11/2008
2	Flutamide (Eulexin)FDA LinkGeneric 06/2009 - 11/2005
2	Goserelin (Zoladex)FDA Link 06/2009 - 11/2005
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Carisoprodol (Soma)FDA LinkGeneric 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2020
1	Hormones (Hormone)IBA 07/2017
1	Diphosphonates (Bisphosphonates)IBA 09/2014
1	xylometazoline (stas)IBA 09/2014
1	nasIBA 05/2013
1	Dihydrotachysterol (AT 10)IBA 01/2012
1	Indicators and Reagents (Reagents)IBA 03/2009

21	Radiotherapy 01/2022 - 11/2005
10	Therapeutics 01/2022 - 05/2007
3	Castration 08/2020 - 02/2012
2	Aftercare (After-Treatment) 07/2017 - 02/2012
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2020
1	Brachytherapy 01/2020
1	Denervation 01/2020
1	Neoadjuvant Therapy 09/2010
1	Salvage Therapy 11/2005